Logos Capital is a fundamental biotechnology-focused fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare.
Member count:1-10
Investment Stage: Series B
Team 7
| Date | Name | Title | Description |
| 27.10.2022 | Riki Harad... | Controller | Riki serves as the Controller ... |
| - | Dr. Graham... | General Pa... | Dr. Walmsley serves as General... |
| - | Dr. Ed Zho... | Partner, A... | Dr. Zhong serves as Head of Lo... |
| - | Virginia Y... | Chief Fina... | Virginia serves as Chief Finan... |
| - | Edward Cal... | Chief Oper... | Edward serves as Chief Operati... |
| - | Yanni Sour... | Partner, R... | Yanni serves as Head of Resear... |
| - | Dr. Arsani... | Managing P... | Dr. William serves as Managing... |
Portfolio 53
| Date | Name | Website | Status | Description |
| 27.08.2021 | Willow | onewillow.... | Current | - |
| 17.08.2021 | GH Researc... | ghres.com/ | Current | - |
| 17.08.2021 | Boundless ... | boundlessb... | Current | - |
| 17.08.2021 | 858 THERAP... | - | Current | - |
| 17.08.2021 | Nuvalent I... | nuvalent.c... | Current | - |
| 17.08.2021 | Element Bi... | elementbio... | Current | - |
| 17.08.2021 | Ventyx Bio... | ventyxbio.... | Current | - |
| 17.08.2021 | Janux | januxrx.co... | Current | - |
| 17.08.2021 | Graphite B... | graphitebi... | Current | - |
| 17.08.2021 | Century Th... | centurytx.... | Current | - |
Show more
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 14.09.2021 | Vanqua Bio... | – Novel drug-development appro... | - | - | marketscre... |
| 09.01.2021 | Visen Phar... | Visen Pharmaceuticals, a Shang... | China | - | finsmes.co... |